NCT03457753View on ClinicalTrials.gov

Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 1, 2018

Primary Completion Date

March 27, 2018

Study Completion Date

March 27, 2018

Conditions
ALS
Interventions
DRUG

Riluzole Oral Soluble Film

Riluzole Oral Soluble Film (ROSF) containing Riluzole 50mg .

Trial Locations (1)

75214

Texas Neurology, P.A., Dallas

Sponsors

Collaborators (2)

Inventiv Health
Covance
All Listed Sponsors
collaborator

Inventiv Health

UNKNOWN

collaborator

Covance

INDUSTRY

lead

Aquestive Therapeutics

INDUSTRY

NCT03457753 - Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter